Dr Subodh Verma is a cardiac surgeon-scientist at St. Michael’s Hospital, Professor at the University of Toronto and the Canada Research Chair in Atherosclerosis.
Published: 25 August 2020
In this Educational Symposium from the e-SPACE Heart Failure Global Web-Conference, Subodh Verma, Nikolaus Marx and Shelley Zieroth discuss SGLT2 inhibitors covering their history, a clinical perspective into what we have learned about them and how future trials might affect clinical practice.
Welcome & IntroductionsWatch now
A Brief History of SGLT2 InhibitorsWatch now
What Have We Learned About SGLT2 Inhibitors? A Clinical PerspectiveWatch now
How Might Future Trials Affect How I Treat My Patients?Watch now
Panel discussionWatch now